HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William B White Selected Research

naproxen-n-butyl nitrate

5/2011Effects of naproxcinod on blood pressure in patients with osteoarthritis.
9/2009Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William B White Research Topics

Disease

92Hypertension (High Blood Pressure)
04/2022 - 02/2002
35Type 2 Diabetes Mellitus (MODY)
04/2022 - 05/2003
22Heart Failure
10/2021 - 02/2002
20Acute Coronary Syndrome
01/2021 - 10/2011
18Myocardial Infarction
10/2021 - 02/2002
18Stroke (Strokes)
10/2021 - 02/2002
11Osteoarthritis
01/2018 - 04/2002
10Arthritis (Polyarthritis)
05/2009 - 02/2002
8Chronic Renal Insufficiency
04/2022 - 10/2003
8Diabetes Mellitus
01/2016 - 05/2003
7Isolated Systolic Hypertension
07/2021 - 02/2003
7Hyperkalemia
01/2018 - 06/2005
6Gout
01/2022 - 08/2011
6Cardiovascular Diseases (Cardiovascular Disease)
03/2018 - 04/2003
6Pain (Aches)
01/2018 - 08/2004
6Essential Hypertension
12/2012 - 04/2002
5Parkinson Disease (Parkinson's Disease)
04/2017 - 10/2002
4Overactive Urinary Bladder (Overactive Bladder)
04/2022 - 06/2018
4Edema (Dropsy)
04/2014 - 02/2002
4Kidney Diseases (Kidney Disease)
06/2012 - 07/2005
3Diabetic Nephropathies (Diabetic Nephropathy)
04/2022 - 05/2003
3Dizziness (Lightheadedness)
01/2019 - 11/2004
3Unstable Angina
08/2018 - 10/2013
3Rheumatoid Arthritis
01/2018 - 07/2004
3Orthostatic Hypotension (Postural Hypotension)
04/2017 - 10/2016
3Coronary Disease (Coronary Heart Disease)
01/2017 - 01/2007
3White Coat Hypertension
10/2014 - 02/2002
3Masked Hypertension
08/2012 - 05/2008
3Angioedema
07/2011 - 07/2002
2Hypogonadism (Hypergonadotropic Hypogonadism)
11/2021 - 01/2021
2Anemia
01/2021 - 12/2019
2Headache (Headaches)
01/2019 - 12/2011
2Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 10/2013
2Pure Autonomic Failure
04/2017 - 10/2016
2Multiple System Atrophy
04/2017 - 10/2016

Drug/Important Bio-Agent (IBA)

34Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 02/2002
23Angiotensin Receptor AntagonistsIBA
11/2018 - 06/2005
19alogliptinIBA
07/2021 - 10/2011
16Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2018 - 04/2002
13DiureticsIBA
11/2018 - 11/2002
13Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2018 - 02/2002
12Hydrochlorothiazide (Esidrix)FDA LinkGeneric
11/2018 - 04/2003
12Pharmaceutical PreparationsIBA
01/2018 - 04/2003
11azilsartan medoxomilIBA
11/2018 - 03/2011
11Valsartan (Vals)FDA Link
04/2016 - 05/2003
10PotassiumIBA
10/2019 - 04/2002
10Telmisartan (Micardis)FDA Link
01/2012 - 07/2002
9Spironolactone (Aldactone)FDA LinkGeneric
01/2021 - 05/2011
8AldosteroneIBA
04/2022 - 05/2003
7Mineralocorticoid Receptor AntagonistsIBA
04/2022 - 06/2005
7Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2011
7Eplerenone (Inspra)FDA LinkGeneric
11/2018 - 05/2003
7Hypoglycemic Agents (Hypoglycemics)IBA
01/2018 - 10/2011
7Celecoxib (Celebrex)FDA Link
01/2018 - 02/2002
7ReninIBA
11/2013 - 07/2005
6AmberIBA
01/2021 - 01/2018
6Calcium Channel Blockers (Blockers, Calcium Channel)IBA
11/2018 - 11/2002
6Chlorthalidone (Chlortalidone)FDA LinkGeneric
11/2018 - 08/2012
6Naproxen (Naprosyn)FDA LinkGeneric
01/2018 - 07/2004
6Dipeptidyl-Peptidase IV InhibitorsIBA
01/2017 - 10/2011
6Amlodipine (Norvasc)FDA LinkGeneric
04/2014 - 07/2002
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2008 - 04/2002
6CalciumIBA
04/2007 - 02/2003
5omega-Chloroacetophenone (Mace)IBA
10/2021 - 09/2013
5patiromerIBA
01/2021 - 01/2018
5olmesartanIBA
11/2018 - 03/2011
5Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2015 - 09/2006
5SodiumIBA
11/2013 - 09/2005
5Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2008 - 08/2003
4Allopurinol (Remid)FDA LinkGeneric
01/2022 - 08/2011
4Brain Natriuretic Peptide (Natrecor)FDA Link
07/2021 - 05/2015
4Xanthine OxidaseIBA
01/2019 - 07/2012
4ThiazidesIBA
11/2018 - 08/2012
41,4-dihydropyridine (dihydropyridine)IBA
01/2015 - 02/2003
4Hormones (Hormone)IBA
06/2011 - 09/2005
4Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2011 - 05/2009
4drospirenoneFDA LinkGeneric
01/2008 - 09/2005
3FebuxostatFDA Link
01/2022 - 07/2012
3Uric Acid (Urate)IBA
01/2022 - 08/2011
3Ibuprofen (Motrin)FDA LinkGeneric
01/2018 - 07/2004
3Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2018 - 10/2013
3DroxidopaIBA
04/2017 - 10/2016
3Renin InhibitorsIBA
03/2012 - 10/2010
3aliskirenFDA Link
03/2012 - 10/2010
3AngiotensinsIBA
09/2009 - 07/2005
2testosterone undecanoateIBA
11/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2019
2salicylhydroxamic acid (SHAM)IBA
01/2019 - 10/2014
2Lipocalin-2IBA
01/2019 - 01/2018
2Cystatin CIBA
01/2019 - 01/2018
2mirabegronIBA
11/2018 - 06/2018
2Muscarinic AntagonistsIBA
11/2018 - 06/2018
2Adrenergic Receptors (Adrenergic Receptor)IBA
08/2018 - 06/2018
2Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2017 - 10/2016
2ProdrugsIBA
04/2017 - 10/2016
2Sodium-Glucose Transporter 2 InhibitorsIBA
01/2017 - 04/2014
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2017 - 01/2016

Therapy/Procedure

55Therapeutics
07/2021 - 11/2002
4Denervation
01/2019 - 11/2013
4Drug Therapy (Chemotherapy)
10/2014 - 07/2005